Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 287

The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.

NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

Vinik, Aaron I., Woltering, Eugene A., Warner, Richard R. P., Caplin, Martyn, O'Dorisio, Thomas M., Wiseman, Gregory A., Coppola, Domenico, Go, Vay Liang W.·2010·Pancreas

Abstract

Neuroendocrine tumors (NETs) are rare, slow-growing neoplasms characterized by their ability to store and secrete different peptides and neuroamines.1 Some of these substances cause specific clinical syndromes,2 whereas other may have elevated plasma or urine levels that are not associated with specific syndromes or symptom complexes Unfortunately, there is no "ideal neuroendocrine tumor marker,"3 but according to the presentation, the sensitivity and specificity of each marker vary, and it is generally possible to choose those of greatest value for each clinical syndrome. The biochemical markers are those hormones or amines secreted by the neuroendocrine cells from which these tumors are derived. Some of these are not specific to any tumor, but are produced and secreted by most NETs, whereas other biochemical markers are more specific to the type of tumor and where their quantification can lead to the suspicion or confirmation of the presence of such a tumor. The annual incidence of NETs has risen to 40 to 50 cases per million, perhaps because of better diagnosis and the availability of highly specific and sensitive ways to measure these tumors' products, improved immunohistochemistry, and enhanced techniques for tumor detection. Thus, the perceived increase in incidence may not be a real change in the incidence of the disease. There are a number of impediments to the diagnosis of these tumors. They are rare, comprising less than 2% of gastrointestinal (GI) malignancies, and are therefore not high on the list of causes of specific symptom complexes. Symptoms themselves are often nonspecific and do not lend themselves readily to identifying the specific underlying tumor. In addition, the manifestations are protean and mimic a variety of disorders. Tumors may be found incidentally on laparoscopy for abdominal pain or during the surgical removal of an appendix or even during a computerized tomographic scan of the abdomen for unexplained symptoms. Lung carcinoids may present with hemoptysis or asthma-like symptoms, and midgut carcinoids may be confused with irritable bowel syndrome (IBS). The natural history of this disease is invariably attended by a long history of vague abdominal symptoms, a series of visits to a primary care practitioner, and referral to a gastroenterologist, often with a misdiagnosis of IBS. These symptoms persist with a median latency to correct diagnosis of 9.2 years by which time the tumor has metastasized, causing symptoms such as flushing and diarrhea and progressing on its slow but relentless course until the patient dies. Clearly, a greater index of suspicion and a carcinoid tumor profile screen are warranted for all patients presenting with "traditional IBS symptoms." Midgut carcinoids are associated with mesenteric fibrosis, which can compress mesenteric vessels and cause bowel ischemia and malabsorption, which may be found in the absence of an abdominal mass. The diagnosis of metastases to the liver is generally more obvious but often still takes place only after a delay of many years. Even then, an incorrect diagnosis is not uncommon. Unless biopsy material is examined for the secretory peptides chromogranin, synaptophysin, or neuron-specific enolase (NSE), tumors may be labeled erroneously as adenocarcinoma, with a negative impact on physician's attitudes regarding management and underestimation of prospects for survival.4 The common symptomatic manifestations of patients with carcinoid tumors are illustrated in Tables 1 and 2.TABLE 1: Clinical Presentations, Syndromes, Tumor Types, Sites, and Hormones4TABLE 2: Clinical Presentation, Syndrome, Tumor Type of Ectopic Pancreatic Tumors, and the Hormones ProducedFlushing It is vitally important to obtain a good history of the nature of the flushing to ascertain whether this can be ascribed to a NET. Is the flushing wet or dry? If dry, it is almost always due to a NET. If it is wet, it may still be due to a NET, but the diaphoresis is due to coexistent anxiety. Intermittent flushing suggests menopause or a NET, for example, systemic mastocytosis or pheochromocytoma. Constant flushing is found with alcoholism, polycythemia, and mitral valve disease, either stenosis or prolapse. If there is a facial rash, it may be rosacea, and if more diffuse, consider mastocytosis with the attendant dermatographia or If there are associated symptoms or such as this suggests a NET, either carcinoid or of the with mastocytosis or and suggests or in NETs is different on the of the tumor. The flushing in carcinoid tumors is dry, long and and has a or in to the common in other It is to and in the and but can the and it can lead to a after Midgut In midgut it is to and the and as as the The is by and and the may and It is only a and may many per many patients may a with a and The diagnosis of flushing the of and and all those causes from a carcinoid tumor, the in the of the it is to is the flushing of and in carcinoid syndrome has ascribed to and the of

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpa.0b013e3181ebaffd

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 287

Metadata

Authors
Vinik, A. I., Woltering, E. A., Warner, R. R. P., Caplin, M., O'Dorisio, T. M., Wiseman, G. A., Coppola, D., & Go, V. L. W.
Venue
Pancreas
Published
2010-08
Volume
39
Issue
6
Pages
713-734
ISSN
0885-3177 (ISSN-L)
OpenAlex
W1969709966
Cited by
287
References
168
FWCI
11.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.